Analyst Research: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

11:31am EDT
Price Change (% chg)

CHF-1.45 (-1.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (NVS). A detailed report, including free correlated market analysis, and updates. 12:29am EDT Stock Traders Daily 10 20.00
ValuEngine Detailed Valuation Report for NVS 23 Apr 2014 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Novartis AG 21 Apr 2014 Wright Reports 42 75.00
"The Economy Matters" Report for NVS: the economy's impact on NVS's price and risk, featuring the powerful Economic Climate Rating 21 Apr 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
Novartis AG ADS 19 Apr 2014 S&P Capital IQ – STARS Reports 11 127.00
Novartis AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 19 Apr 2014 Reuters Investment Profile 12 20.00
NOVARTIS AG-ADR (NVS) Zacks Company Snapshot 16 Apr 2014 Zacks Investment Research Inc. 1 12.00 Ratings Stock Report For: NOVARTIS AG (NVS) 12 Apr 2014 Ratings 5 10.00
Name Age Since Current Position

Joerg Reinhardt

58 2013 Chairman of the Board

Joseph Jimenez

2010 Chief Executive Officer, Member of the Executive Committee

Ulrich Lehner

67 2006 Vice Chairman of the Board of Directors, Non-Executive Director

Harry Kirsch

2013 Member of the Management Board, Chief Financial Officer

Peter Kornicker

2011 Chief Compliance Officer
Search Stocks